Giuseppe D. F.
- Country
- Italy
- Department
- Neurology
Research Overview
- Evaluation of Safety and Efficacy of PRI-002 in Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Latozinemab in Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Phase 1/2 Multicenter Study Evaluating Safety and Efficacy of AVB-101 via Bilateral Intrathalamic Infusion in Frontotemporal Dementia with Progranulin Mutations
Data & Insights
Has run more than one trial at 14 of 72 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in various forms of neurodegenerative conditions, with particular emphasis on different types of dementia and related disorders.
- Frontotemporal Dementia (FTD)
- Alzheimer's Disease
- Prion Diseases
The investigator's work encompasses both genetic and non-genetic forms of these conditions.
Therapeutic Applications
The investigator focuses on evaluating novel therapeutic approaches for neurodegenerative diseases, including:
- Gene-targeted therapies
- Intrathecal drug administration
- Novel pharmaceutical compounds
Their research includes investigation of treatments for specific genetic mutations associated with frontotemporal dementia.
Clinical Assessment
The investigator employs specialized clinical assessment methods focusing on:
- Cognitive function evaluation
- Disease progression monitoring
- Safety and tolerability assessment
Their work includes evaluation of both symptomatic and disease-modifying treatments across various stages of neurodegeneration.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.